Boston Scientific Corp. (NYSE:BSX) finally pulled the trigger Thursday, saying it would sell a major business to Stryker Corp. It just wasn't the business Wall Street was expecting it to sell.
Stryker Corp.'s (NYSE:SYK) biotech subsidiary, its former president and three sales reps are hoping a judge will agree to dismiss 12 of the 16 criminal charges pending against them in a federal beef. Hopkinton, Massachusetts-based Stryker Biotech, former president Mark Philip and the sales reps were indicted last year for allegedly promoting the off-label use of a pair of bone-growth products and lying to the Food & Drug Administration.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Stryker Corp. (NYSE: SYK) has agreed to buy Gaymar Industries Inc., the medical products maker in Orchard Park, New York, for $150 million in cash. Founded in 1956, Gaymar Industries specializes in support surface, pressure ulcer and, temperature management equipment and supplies for institutions and homes.
Despite a big uptick in surgical equipment sales, Stryker Corp. (NYSE:SYK) narrowly missed second-quarter revenue forecasts, but still managed to meet analysts’ estimates for a $319 million profit. Global net sales rose 7.6 percent to $1.76 billion, a 7.6 percent increase over the three months ended June 30, 2009. Much of the jump in revenues […]
Stryker Corp. (NYSE:SYK) said the Food & Drug Administration cleared an implant factory in Cork, Ireland, and a Michigan distribution facility of problems flagged in a pair of warning letters issued in 2007 and 2009. According to a heavily redacted copy of the 2007 warning letter on the FDA’s website, an inspection of the Cork […]
A federal judge in New York dismissed a lawsuit accusing Stryker Corp. (NYSE:SYK) subsidiary Howmedica Osteonics of manufacturing a defective knee implant. Beverly Maxwell had a total knee replacement in June 2004, using Howmedica’s Duracon Total Knee System. Maxwell developed an allergic reaction to the nickel contained in the Duracon device, which was replaced in […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.